Pharmaxis
Pharmaxis progresses LOX inhibitor to phase 2 cancer study
Botanix Pharmaceuticals
Botanix secures FDA status for BTX 1801
Medical Developments International
Another approval for MVP's Penthrox
Auscann Group Holdings
AusCann completes study recruitment
Medadvisor
MedAdvsor helps to address isolation and quarantining issues during COVID-19 pandemic
Bellevue Gold
BGL – Macquarie rates the stock as Outperform
Perseus Mining
Perseus Mining outlines positive quarter with strong cashflows
Hotel Property Investments
Monash IVF Group
Volpara Health Technologies
Overnight: Back To Work
The Overnight Report: Back To Work
Bubs Australia
$3,000 invested in these 3 shares could make you a fortune over the next 10 years